JP2009533367A5 - - Google Patents

Download PDF

Info

Publication number
JP2009533367A5
JP2009533367A5 JP2009504628A JP2009504628A JP2009533367A5 JP 2009533367 A5 JP2009533367 A5 JP 2009533367A5 JP 2009504628 A JP2009504628 A JP 2009504628A JP 2009504628 A JP2009504628 A JP 2009504628A JP 2009533367 A5 JP2009533367 A5 JP 2009533367A5
Authority
JP
Japan
Prior art keywords
antibody
antibody according
amount
less
acc2795
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009504628A
Other languages
English (en)
Japanese (ja)
Other versions
JP4718634B2 (ja
JP2009533367A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/003165 external-priority patent/WO2007115814A2/en
Publication of JP2009533367A publication Critical patent/JP2009533367A/ja
Publication of JP2009533367A5 publication Critical patent/JP2009533367A5/ja
Application granted granted Critical
Publication of JP4718634B2 publication Critical patent/JP4718634B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009504628A 2006-04-11 2007-04-10 インスリン様増殖因子i受容体及びその使用 Active JP4718634B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06007571 2006-04-11
EP06007571.0 2006-04-11
PCT/EP2007/003165 WO2007115814A2 (en) 2006-04-11 2007-04-10 Antibodies against insulin-like growth factor i receptor and uses thereof

Publications (3)

Publication Number Publication Date
JP2009533367A JP2009533367A (ja) 2009-09-17
JP2009533367A5 true JP2009533367A5 (enExample) 2010-11-11
JP4718634B2 JP4718634B2 (ja) 2011-07-06

Family

ID=36940705

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009504628A Active JP4718634B2 (ja) 2006-04-11 2007-04-10 インスリン様増殖因子i受容体及びその使用

Country Status (20)

Country Link
US (1) US20080014203A1 (enExample)
EP (2) EP2007810B1 (enExample)
JP (1) JP4718634B2 (enExample)
KR (2) KR101276513B1 (enExample)
CN (1) CN101421305B (enExample)
AR (1) AR060592A1 (enExample)
AU (1) AU2007236199B2 (enExample)
BR (1) BRPI0710185B8 (enExample)
CA (2) CA3081707A1 (enExample)
CR (1) CR10301A (enExample)
EC (1) ECSP088816A (enExample)
ES (1) ES2403075T3 (enExample)
IL (1) IL194397A (enExample)
MX (1) MX2008012950A (enExample)
NO (1) NO20084082L (enExample)
NZ (1) NZ571414A (enExample)
RU (1) RU2541765C2 (enExample)
UA (1) UA95284C2 (enExample)
WO (1) WO2007115814A2 (enExample)
ZA (1) ZA200808597B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7846724B2 (en) * 2006-04-11 2010-12-07 Hoffmann-La Roche Inc. Method for selecting CHO cell for production of glycosylated antibodies
US20090068110A1 (en) * 2006-12-22 2009-03-12 Genentech, Inc. Antibodies to insulin-like growth factor receptor
PE20090368A1 (es) 2007-06-19 2009-04-28 Boehringer Ingelheim Int Anticuerpos anti-igf
CA2709029A1 (en) 2007-12-21 2009-07-02 Bianca Eser Stability testing of antibodies
PE20120415A1 (es) 2008-12-12 2012-05-09 Boehringer Ingelheim Int Anticuerpos anti-igf
WO2010112194A1 (en) * 2009-04-02 2010-10-07 F. Hoffmann-La Roche Ag Antigen-binding polypeptides and multispecific antibodies comprising them
US20100316639A1 (en) 2009-06-16 2010-12-16 Genentech, Inc. Biomarkers for igf-1r inhibitor therapy
JP5921433B2 (ja) 2009-07-24 2016-05-24 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 攪拌システム
CA2774953A1 (en) 2009-10-07 2011-04-14 The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services Human domain antibodies against components of the human insulin-like growth factor (igf) system
KR102071834B1 (ko) 2009-10-26 2020-01-30 에프. 호프만-라 로슈 아게 글리코실화된 면역글로불린의 제조 방법
WO2011101328A2 (en) 2010-02-18 2011-08-25 Roche Glycart Ag Treatment with a humanized igg class anti egfr antibody and an antibody against insulin like growth factor 1 receptor
WO2011135040A1 (en) 2010-04-30 2011-11-03 F. Hoffmann-La Roche Ag Fluorescent antibody fusion protein, its production and use
KR101593766B1 (ko) 2010-11-05 2016-02-15 에프. 호프만-라 로슈 아게 혼합식 크로마토그래피에 의한 최적화된 항체 포획 방법
CN110229235A (zh) 2011-06-22 2019-09-13 霍夫曼-拉罗奇有限公司 利用包含mhc i类的复合物通过循环中的病毒特异性细胞毒性t细胞清除靶细胞
RU2502798C2 (ru) * 2012-02-22 2013-12-27 Общество с ограниченной ответственностью "Фармако Биотех" КЛЕТОЧНАЯ ЛИНИЯ huFSHIK, СЕКРЕТИРУЮЩАЯ РЕКОМБИНАНТНЫЙ ЧЕЛОВЕЧЕСКИЙ ФСГ
EP2914629A1 (en) 2012-11-05 2015-09-09 MAB Discovery GmbH Method for the production of multispecific antibodies
EP2727941A1 (en) 2012-11-05 2014-05-07 MAB Discovery GmbH Method for the production of multispecific antibodies
CA2889788A1 (en) 2012-12-21 2014-06-26 F. Hoffmann-La Roche Ag Disulfide-linked multivalent mhc class i comprising multi-function proteins
US20140255413A1 (en) 2013-03-07 2014-09-11 Boehringer Ingelheim International Gmbh Combination therapy for neoplasia treatment
WO2021119234A1 (en) * 2019-12-10 2021-06-17 Horizon Pharma Ireland Ltd. Glycosylated antibodies against insulin-like growth factor i receptor and uses thereof
TW202228775A (zh) 2020-10-14 2022-08-01 美商維里迪恩醫療股份有限公司 用於治療甲狀腺眼病之組合物及方法
EP4384219A4 (en) 2021-08-10 2025-06-18 Viridian Therapeutics, Inc. COMPOSITIONS, DOSAGES AND METHODS FOR THE TREATMENT OF THYROID EYE DISEASE

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675187A (en) 1983-05-16 1987-06-23 Bristol-Myers Company BBM-1675, a new antibiotic complex
US5204244A (en) * 1987-10-27 1993-04-20 Oncogen Production of chimeric antibodies by homologous recombination
US5202238A (en) * 1987-10-27 1993-04-13 Oncogen Production of chimeric antibodies by homologous recombination
US5770429A (en) * 1990-08-29 1998-06-23 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
GB9022543D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Antibody production
US5650508A (en) * 1991-12-27 1997-07-22 Georgia Tech Research Corporation Peptide ketoamides
MD1367C2 (ro) 1992-11-13 2000-11-30 Idec Pharmaceuticals Corporation Metode de tratament al limfomului celulelor B, anticorpi anti-CD20, hibridom.
EP2275540B1 (en) * 1999-04-09 2016-03-23 Kyowa Hakko Kirin Co., Ltd. Method for controlling the activity of immunologically functional molecule
US20030165502A1 (en) * 2000-06-13 2003-09-04 City Of Hope Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth
US7241444B2 (en) * 2002-01-18 2007-07-10 Pierre Fabre Medicament Anti-IGF-IR antibodies and uses thereof
US7553485B2 (en) * 2002-01-18 2009-06-30 Pierre Fabre Medicament Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof
WO2003100008A2 (en) * 2002-05-24 2003-12-04 Schering Corporation Neutralizing human anti-igfr antibody
EP1613658B1 (en) * 2003-04-02 2012-03-14 F. Hoffmann-La Roche AG Antibodies against insulin-like growth factor i receptor and uses thereof
AR046071A1 (es) * 2003-07-10 2005-11-23 Hoffmann La Roche Anticuerpos contra el receptor i del factor de crecimiento de tipo insulinico y los usos de los mismos
EP1666501A4 (en) * 2003-08-11 2008-12-24 Chugai Pharmaceutical Co Ltd ANTI-HM1.24 ANTIBODIES WITH MODIFIED SUGAR CHAIN
EP1693069B1 (en) * 2003-10-10 2013-07-24 Chugai Seiyaku Kabushiki Kaisha Remedy for solid tumor

Similar Documents

Publication Publication Date Title
JP2009533367A5 (enExample)
AU2013229786B2 (en) Conditionally active anti-epidermal growth factor receptor antibodies and methods of use thereof
JP6282745B2 (ja) 修飾抗上皮成長因子受容体抗体およびその使用法
JP7654346B2 (ja) 多重特異性抗体およびその使用
JP2009114201A5 (enExample)
JP2017071606A5 (enExample)
JP2009532336A5 (enExample)
JP2014533279A5 (enExample)
JP2011507932A5 (enExample)
PT2576618T (pt) Anticorpos contra gdf8 humano
WO2017161206A1 (en) Conjugates containing conditionally active antibodies or antigen-binding fragments thereof, and methods of use
JP2019527194A5 (enExample)
JP2015533781A5 (enExample)
KR20200013231A (ko) 항암 조합 요법
CA3158579A1 (en) Heavy chain antibodies binding to cd38
JP2018512402A5 (enExample)
JP2020527152A5 (enExample)
WO2018183366A1 (en) Combination therapies of csf-1r or csf-1 antibodies and a t-cell engaging therapy
JP2023537078A (ja) COVID-19を治療及び防止するためのSARS-CoV-2抗体
TW202124432A (zh) 使用pd-1軸抑制劑及抗骨膜蛋白抗體治療癌症之方法
US20250257141A1 (en) Combination therapy for the treatment of cancer comprising a fas axis antagonist and a t-reg cell depleting agent antagonist
JP7668943B2 (ja) 多重特異性抗体およびその使用
US20220218838A1 (en) Adc for a treatment concomitant with or subsequent to docetaxel
WO2025072516A1 (en) Methods of reducing weight loss using anti-gdf15 antibodies
JP2025036273A (ja) 多重特異性抗体およびその使用